Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases
The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Compared to intravitreal injection, subretinal injection has more direct effects on the targeting cells in the subretinal space, which provides a new therapeutic method for vitreoretinal diseases, especially when gene therapy and/or cell therapy is involved. To date, subretinal delivery has been widely applied by scientists and clinicians as a more precise and efficient route of ocular drug delivery for gene therapies and cell therapies including stem cells in many degenerative vitreoretinal diseases, such as retinitis pigmentosa, age-related macular degeneration, and Leber's congenital amaurosis. However, clinicians should be aware of adverse events and possible complications when performing subretinal delivery. In the present review, the subretinal injection used in vitreoretinal diseases for basic research and clinical trials is summarized and described. Different methods of subretinal delivery, as well as its benefits and challenges, are also briefly introduced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subretinal drug is administered between the retinal photoreceptor cells and the RPE layer, requires less vector than intravitreal injections to achieve a therapeutic effect on the retina.127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
In the citing paper
“Despite these advantages, intravitreal injections also carry risks of adverse reactions, including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and due to the repeated use of these injections in various treatments, patient compliance can become an issue.119,127,129”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
In the citing paper
“However, this route of administration can further damage an already damaged retina, leading to retinal or RPE detachment from underlying layers, hemorrhage, and changes in retinal pigmentation.35,127,128”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
In the citing paper
“Most gene therapy viral vectors given intravitreally, fail to adequately transduce photoreceptors and RPE, due to the inner limiting membrane that divides the vitreous from the retina.1,15,119,127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [127]
Citations
Cites
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Embryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Cited by
Items 101–180 of 180
Song, Z., Xu, L., Wang, J., Rasti, R., Sastry, A., Li, J. D., Raynor, W., Izatt, J. A., Toth, C. A., Vajzovic, L. M., et al. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.07.020 · Cited by 11
“(1)-(3), was used to enhance the variety of the training data set by changing the shape of the bleb.”
BackgroundMethodTawfik, M., Hadlak, S., Götze, C., Sokolov, M., Kulikov, P. P., Николаевич, К. А., Shtilman, M. I., Sabel, B. A., & Henrich‐Noack, P. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3073 · Cited by 10
Sharper vision, steady hands: can robots improve subretinal drug delivery? Systematic review
Łajczak, P. M., & Nawrat, Z. (2024) · Journal of Robotic Surgery · doi:10.1007/s11701-024-01991-x · Cited by 10
“…injections rely on diffusion from intravitreal cavity, resulting in lower absorption due to the presence of impermeable internal limiting membrane [17–20] This systematic review explored the potential of robot-assisted subretinal injection (RA SI) as a drug delivery method for retinal diseases.”
BackgroundLong-acting delivery and therapies for neovascular age-related macular degeneration
Rowe, L. W., & Ciulla, T. A. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2374869 · Cited by 12
“…administration to avoid the potential complications of pars plana vitrectomy associated procedures such as macular hole and/or potential photoreceptor disruption associated with bleb creation, reti-notomy with hemorrhage and/or fibrosis, retinal tear and detachment, cataract, etc (Figure 3) [108].”
Lederer, C. W., Koniali, L., Buerki‐Thurnherr, T., Papasavva, P. L., Grutta, S. L., Licari, A., Štaud, F., Bonifazi, D., & Kleanthous, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040793 · Cited by 10
Gene Augmentation for Autosomal Dominant CRX-Associated Retinopathies
Sun, C., & Chen, S. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-27681-1_21 · Cited by 9
A non‐surgical method for subretinal delivery by trans‐scleral microneedle injection
Hejri, A., Chrenek, M. A., Goehring, N. T., Bowland, I. I., Noel, R. K., Yan, J., Nickerson, J. M., & Prausnitz, M. R. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10755 · Cited by 8
“2,17 The first Food and Drug Administration-approved gene therapy product, for instance, is an ocular treatment administered by subretinal injection of a viral vector.”
Retinoid dynamics in vision: from visual cycle biology to retina disease treatments
Swigris, J., Widjaja‐Adhi, M. A. K., & Golczak, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108902 · Cited by 8
Zakir, R., Iqbal, K., Ali, M. H., Mirza, U. T., Mahmood, K., Riaz, S., & Hashmani, N. (2022) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2022.12 · Cited by 8
Liu, L., Rambarran, T., & Sheardown, H. D. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2088531 · Cited by 10
Li, Z., Fu, P., Wei, B.-T., Wang, J., Li, A.-L., Li, M.-J., & Bian, G.-B. (2022) · Frontiers in Robotics and AI · doi:10.3389/frobt.2022.913930 · Cited by 9
“In recent years, retinal vein cannulation (RVC) has been proposed as an innovative procedure (Peng et al., 2017).”
BackgroundParashar, R., Vyas, A., Sah, A. K., Hemnani, N., Thangaraju, P., & Suresh, P. K. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998240053231009060654 · Cited by 8
Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
Cho, G. Y., Bolo, K. A., Park, K. S., Sengillo, J. D., & Tsang, S. H. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0377-1 · Cited by 8
Dave, V. P., Susaimanickam, P. J., Mir, I. A., Mariappan, I., Basu, S., Reddy, B. G., Pappuru, R. R., Jalali, S., & Das, T. (2019) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_317_19 · Cited by 7
Zeng, L., Wei, Y., Qiu, Y., Bi, R., Peng, H., Hu, B., & Li, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s521960 · Cited by 9
Elbaha, S., Hadi, A. M. A., & Abouhussein, M. A. (2019) · Journal of Ophthalmology · doi:10.1155/2019/6274209 · Cited by 7
“)e effect of a drug delivered in the subretinal space might exceed the effect of the same drug injected intravitreally due to the closer contact with the retina without intervening barriers [28].”
BackgroundSun, D., Sun, W., Gao, S., Lehrer, J., Wang, H., Hall, R. C. W., & Lu, Z. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03679-1 · Cited by 7
“However, subretinal injection can cause complications including retinal tissue degenerations due to its invasive nature to the intricate structures of the subretinal space [36–38].”
Abud, M. B., Baranov, P. Y., Patel, S., Hicks, C. A., Isaac, D. L. C., Louzada, R. N., Dromel, P. C., Singh, D., Sinden, J. D., de Ávila, M. P., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17332 · Cited by 7
Talreja, D., Cashman, S. M., Dasari, B., Kumar, B., & Kumar‐Singh, R. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.05.034 · Cited by 6
“While frequent intravitreal injection is a routine office procedure, subretinal injection is a surgical procedure fraught with potential complications (Buschini et al., 2016; Peng et al., 2017).”
Narrative review-drug delivery in age-related macular degeneration
Israilevich, R. N., Mahmoudzadeh, R., Salabati, M., & Xu, D. N. (2021) · Annals of Eye Science · doi:10.21037/aes-21-8 · Cited by 6
“21037/aes-21-8 invasive technology, such as optical coherence tomography (OCT), (III) ocular immune privilege reduces the risk of significant host-immune response, (IV) an effective therapeutic dose may be achieved with a smaller quantity of viral vector, and (V) systemic exposure is limited due to anatomical barriers…”
BackgroundDiress, M., Ionescu, C. M., Foster, T., Lim, P., Sen, L. Y., Kovačević, B., Wagle, S. R., Mooranian, A., & Al‐Salami, H. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107172 · Cited by 5
Intraoperative optical coherence tomography in ophthalmology: Technologies and applications
Tao, Y. K. K. (2025) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo-d-25-00076 · Cited by 5
Hua, Z., Shen, Y., & Zhou, X. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030282 · Cited by 5
“By injecting carriers into the potential space between the RPE and photoreceptors, a localized drug reservoir with high concentration is created, although this procedure induces a controlled, iatrogenic retinal detachment [147,148].”
Potential of Müller Glial Cells in Regeneration of Retina; Clinical and Molecular Approach.
Heravi, M. M., & Rasoulinejad, S. A. (2022) · International Journal of Organ Transplantation Medicine · Cited by 7
Gene and cell-based therapies for retinal and optic nerve disease
Esposito, E. P., Han, I. C., & Johnson, T. V. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00016-2 · Cited by 5
Noninvasive Framework Nucleic Acid Eye Drops for Retinal Administration
Zhu, S., Yan, Q., Wang, L., Zhu, Y., & Luo, S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00760 · Cited by 4
Liquid-Driven Microinjection System for Precise Fundus Injection
Xu, S., Hu, B., Liu, R., Zhao, X., & Sun, M. (2024) · Sensors · doi:10.3390/s24072140 · Cited by 4
“For intra-vascular injection in retinal artery cannulation and retinal vein cannulation, the surgeons inject thrombolytic drugs into the occluded retinal arteries or veins to lyse the thrombus, thereby restoring blood circulation to the retinal vessels [8,9].”
BackgroundHow Advanced are Nanocarriers for Effective Subretinal Injection?
Guan, J.-X., Wang, Y.-L., & Wang, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479327 · Cited by 5
Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization
Cao, J., Yang, R., Smith, T. E., Evans, S. M., McCollum, G. W., Pomerantz, S. C., Petley, T., Harris, I. R., & Penn, J. S. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.05.007 · Cited by 4
“Notably, although rare, there are adverse events associated with subretinal injection, including retinal detachment, vitreous hemorrhage, recurrence of submacular hemorrhage, and postoperative development of CNV.(55,56)”
BackgroundInfluentialGenes and Gene Therapy in Inherited Retinal Disease
Shughoury, A., Ciulla, T. A., Bakall, B., Pennesi, M. E., Kiss, S., & Cunningham, E. T. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000377 · Cited by 4
Huang, C., Yang, H., Chen, T., & Chen, C. (2023) · International Journal of Medical Robotics and Computer Assisted Surgery · doi:10.1002/rcs.2560 · Cited by 3
Kwok, J., Gray, A. P., Sato, Y., Savina, S., Dolgova, N., Sudharsan, R., Boye, S. L., Boye, S. L., Reichenbacker, S., Meyer, T., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01929-2 · Cited by 3
Haddadzadegan, S., Mehdizdeh, N., Wang, X., Wong, T. T. L., & Miserez, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114841 · Cited by 5
Jung, Y., Lee, S., Rhee, J. K., Lee, C. E., Baker, B. J., & Song, Y. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00740 · Cited by 3
Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
Tun, S. B. B., Shepherdson, E., Tay, H. G., & Barathi, V. A. (2023) · Journal of Visualized Experiments · doi:10.3791/65848 · Cited by 3
Li, F., Li, Z., Li, S., Zhou, H., Guo, Y., Wang, Y., Lei, B., Miao, Y., & Wang, Z. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00461 · Cited by 2
“space on the opposite side of the retina (You et al., 2014; Peng et al., 2017).”
InfluentialA Novel Approach for Suprachoroidal Space Injection: An Experimental Evaluation
Long, J., Wu, X., Hu, P. F., Cui, N., Xu, L., Ye, Y., Chen, H., Peng, Q., Lu, X., & Long, D. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2469829 · Cited by 2
“6 In contrast, the SCS, located between the choroid and sclera, is a potential target for drug delivery.”
Advances in technical methods and applications of subretinal injections in experimental animals
Song, C., Ji, Y., Wang, Y., & Yang, W. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1574519 · Cited by 2
Ophthalmic surgical robot for precise retinal puncture and drug delivery
Wang, C., Liu, M., Zhao, L., Zhang, H., Wang, Q., Zhu, Y., Wang, L., & Zhao, J. (2025) · International Journal of Extreme Manufacturing · doi:10.1088/2631-7990/ae00ff · Cited by 2
“Validated by multiple clinical trials [8–10] , SI has demonstrated superior performance in delivering adeno-associated virus vectors.”
Giudice, G. L., Galan, A., & Gattazzo, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.112174 · Cited by 2
Cutting-Edge Developments in utilizing Lipid Nano-carrier for Enhanced Drug Delivery
Chauhan, S. B., Singh, A., & Singh, I. (2024) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2024.17.5.8 · Cited by 2
Potential therapeutic applications of stem cells in animal models of ocular affections
Hassan, T. A., Abouelela, Y. S., Rizk, H., & Tolba, A. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00380-7 · Cited by 2
Nanoparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations
Sánchez‐López, E., Souto, E. B., Espina, M., Cano, A. C., Ettcheto, M., Camins, A., & García, M. L. (2021) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-76367-1_15 · Cited by 2
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Bower, J. J., Song, Z., & Song, L. (2022) · Journal of Visualized Experiments · doi:10.3791/63532 · Cited by 2
Nezhad, N. M., Rahimi, M., Gheybi, F., Kesharwani, P., Oroojalian, F., & Sahebkar, A. (2025) · Applied Materials Today · doi:10.1016/j.apmt.2025.102602 · Cited by 3
Upadhyay, A. K., Drag, S., Singh, P., Rajanala, K., & Arumugham, R. G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1679619 · Cited by 1
Xu, P., Ourak, M., Borghesan, G., Clerck, I. D., Costa, D. R. D., Haegemans, J., Stalmans, P., & Poorten, E. V. (2025) · IEEE Robotics and Automation Letters · doi:10.1109/lra.2025.3641814 · Cited by 1
Silicon Nanoneedle Patches for Painless, Sustained Treatment of Macular Degeneration
Nguyen, V. P., Jeong, J., Zhe, J., Zheng, M., Lee, J., Tran, K. A., Wei, Z., Lee, C. H., & Paulus, Y. M. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01783 · Cited by 1
Micro-Robotic Surgery in Ophthalmology, Neurosurgery, and Cardiovascular Systems
Vinciya, T., Praveen Javali, R., Shalini, M., Premalatha, V., Tharayil, A. S., Andy, A., & Manjunatha, I. G. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-2600-0358-9.ch009 · Cited by 1
Robotic Systems in Ophthalmologic Surgery
Roizenblatt, M., Ebrahini, A., Iordachita, I. I., & Gehlbach, P. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-35102-0_12 · Cited by 1
Therapeutic approaches and development of genomic diagnostic tools for Usher syndrome
García, C. F. (2020) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/137034 · Cited by 2
Duong, T. T. (2018) · ScholarlyCommons (University of Pennsylvania)
Kumar, A., & Agarwal, D. (2019) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_779_19
“Nowadays, subretinal drug delivery has been extensively used as part of both gene therapy and cell therapy, in clinical as well as experimental settings for the treatment of retinal degenerative diseases like Retinitis Pigmentosa (RP), Leber’s Congenital Amaurosis (LCA), Stargardt’s disease and AMD.[1] In gene therapy…”
InfluentialA 41G subretinal injection cannula integrating a guiding OCT probe
Abid, A., Duval, R., Rezende, F., & Boutopoulos, C. (2021) · Optics in the Life Sciences · doi:10.1364/boda.2021.dm2a.6
Kadkhodaeian, H. A., Salati, A., Sameni, H., & Lashay, A. (2021) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.52547/sjku.26.4.105
Surgical Approach with Pars Plana Vitrectomy for Subretinal Gene Therapy
Breazzano, M. P., Batson, S. A., Tsang, S. H., & Chen, R. W. S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_35
Application of Base Editor-Mediated Genome Editing in Mouse Retina
Wu, J., Cho, C. S., Jo, D. H., & Kim, J. H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2879-9_14
Rayes, E. N. E., Habib, A. M., Soliman, A. H., Ibrahim, O., & Sawwah, K. M. H. E. (2023) · Retina · doi:10.1097/iae.0000000000003654
Mehra, P., Rain, M., Singh, J., Saha, P. K., & Anand, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4715086/v1
Mehra, P., Rain, M., Singh, J., Saha, P. K., & Anand, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4715086/v2
Salim, A., Suryanov, I. P. D., Suteja, R. C., & Andayani, A. (2024) · Journal of Retina-Vitreous · doi:10.37845/ret.vit.2024.33.48
Indications and Surgical Treatments for Inherited Retinal Dystrophies
Ríos, P., & Irigoyen, C. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009100
X-Linked Retinitis Pigmentosa Gene Therapy: Preclinical Aspects
Mansouri, V., & Bemanalizadeh, M. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009101
CNN-Based Assessment of Cannula Placement for Automated Subretinal Injection Procedures
Wang, N., & Chen, C. (2025) · Mechanisms and machine science · doi:10.1007/978-3-031-96081-9_48
Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
Cao, L. Y., Chew, L. A., Finkelstein, S., Amason, J., Dubey, S. K., Flynn, E., Arshavsky, V. Y., Rickman, C. B., & Alekseev, O. (2025) · Journal of Visualized Experiments · doi:10.3791/68631
Perez, A. B., & Molecular, U. A. D. B. D. D. B. I. D. B. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Xu, H., Hu, Y., Xu, Y., Yan, P., Zhong, B., & Liu, W. (2025) · Research Square · doi:10.21203/rs.3.rs-8029636/v1
Long, Y., Jia, Q., Zhang, W., Qin, H., & Yao, K. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5723
Ultrasound-Enhanced Retinal Delivery of Engineered Viral Vectors
Link, S. S., Fan, K., Adame, J., Keehn, C. C., Shen, G., Frankfort, B. J., & Szablowski, J. (2026) · Investigative Ophthalmology & Visual Science · doi:10.64898/2026.01.04.697446
Deep learning-based autonomous robotic retinal surgery
Arikan, D., Esfandiari, M., Gehlbach, P. L., & Nasseri, M. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36556-0.00009-1 · Cited by 1
Gene therapy for age-related macular degeneration: new prospects for vision restoration
Moshetova, L. K., & Soshina, M. M. (2025) · Pharmacogenetics and Pharmacogenomics · doi:10.37489/2588-0527-2025-4-18-28
Moreno, D. A. (2020) · theses.fr (ABES) · doi:10.70675/8c0ccf40z399az4cfcz90bdz7f4915a9b876
Huang, L., Wei, J., Wang, X., Peng, S., Deng, Z., Xu, Y., Wang, Y., & Zhang, Q. (2026) · Research Square · doi:10.21203/rs.3.rs-9000454/v1
Partial Fluid-Air Exchange Enhances Submacular Injection of Retinal Sheets
Baldwin, G. E., Akita, Y., Manabe, K., Kamei, T., Kuwahara, A., Bleicher, I. D., Vavvas, D. G., & Miller, J. B. (2026) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20260310-04
Stem cell therapy in retinal disease
WANG, J., Felfeli, T., & Ballios, B. G. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00004-5
Ocular Safety and Efficacy of AAV-mediated Tyrosinase Gene Augmentation in a Nonhuman Primate ModelPreprint
Lim, J., Larimer-Picciani, A. M., Moshiri, A., Wang, J.-K., Takahashi, N., Raposo, A. C. S., Motta, M. J., Byrne, L. C., & Thomasy, S. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.13.738268
Liu, S., Sun, P., Liu, X., Tan, J., Gong, Y., Chen, J., Xu, Q., Huang, Y., Yang, F., Wang, X., et al. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101190
“Compared with intravitreal injection, subretinal delivery can produce high local exposure using a lower total dose [ 180 ].”
Antioxidant Strategies for Inherited Retinal Degenerations in the Era of Gene Therapy
Yang, Y., Chen, Q., Zeng, J., Liang, L., Tao, Z., She, K., Ren, C., & Lu, F. (2026) · Antioxidants · doi:10.3390/antiox15101229
Ocular Gene Therapy in China: Technological Framework, Clinical Translation, and Future Perspectives
Zhang, D., He, Z., Lu, F., & Yang, Y. (2026) · Human Gene Therapy · doi:10.1177/10430342261495300
Metadata
- Authors
- Peng, Y., Tang, L., & Zhou, Y.
- Affiliations
- Central South University (CN)
- Venue
- Ophthalmic Research
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 58
- Issue
- 4
- Pages
- 217-226
- ISSN
- 0030-3747 (ISSN-L)
- 1423-0259
- OpenAlex
- W2752393253
- Cited by
- 175
- References
- 108
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 27 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 15 · 2019: 14 · 2018: 6
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Ophthalmic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- subretinal injection, ocular drug delivery, vitreoretinal disease, gene therapy, cell therapy, stem cell therapy, retinitis pigmentosa, age-related macular degeneration, Leber congenital amaurosis, degenerative retinal diseases, injection complications
- MeSH terms
- Animals, Genetic Vectors, Humans, Injections, Retina, Retinal Diseases, Genetic Therapy, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.